By SIMON CONSTABLE
A small Scottish-based biotech company could soon win a decisive battle in the war against cancer.
NuCana, led by biotech industry veteran Hugh Griffith, is developing therapies that could radically change cancer treatment. Despite only being founded in 2008 the firm has already captured the interest of investors with good results from clinical trials of the compounds. Read more here.